Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Scand J Gastroenterol ; 52(2): 185-192, 2017 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-27797273

RESUMEN

BACKGROUND: The condition non-coeliac gluten sensitivity (NCGS) is clinically similar to coeliac disease, but lack objective diagnostic criteria. Symptom relief on gluten-free diet followed by gluten containing food challenge may confirm the condition in clinical settings. AIM: To describe the results of an open bread challenge in patients with suspected NCGS, and to compare the results with recently suggested cut-offs for symptom change. MATERIAL AND METHODS: Fifty-six patients (12 males) self-instituted on gluten-free diet with negative coeliac disease diagnostics were examined for NCGS by an open bread challenge. Symptoms were reported by Gastrointestinal Symptom Rating Scale, IBS-version (GSRS-IBS) and visual analogue scale (VAS). Results were retrospectively compared to the Salerno and Monash cut-offs for symptom change. RESULTS: Forty-seven patients were diagnosed with NCGS. Total GSRS-IBS score and overall symptoms by VAS increased significantly in NCGS (p < .001), but not in non-NCGS patients (p < .12 and p = .08, respectively). Total GSRS-IBS challenge score and overall symptoms by VAS were significantly higher in NCGS than in non-NCGS patients (53 vs. 37, p = .004 and 76 vs. 39 mm, p = .02, respectively). Applying the Salerno and Monash cut-offs, 63 and 75% would be classified with NCGS, respectively. According to total GSRS-IBS absolute agreement was lowest between clinician's diagnosis and Salerno cut-off (63%) and highest between Salerno and Monash cut-offs (88%). CONCLUSION: Clinician diagnosed 85% with NCGS. The proportion of NCGS was lower according to the Salerno and Monash cut-offs. The Salerno cut-off should be the starting point for a common definition of symptom change.


Asunto(s)
Enfermedad Celíaca/diagnóstico , Dieta Sin Gluten , Glútenes/efectos adversos , Hipersensibilidad al Trigo/diagnóstico , Adulto , Anciano , Diagnóstico Diferencial , Femenino , Humanos , Masculino , Persona de Mediana Edad , Noruega , Estudios Retrospectivos , Autoinforme , Índice de Severidad de la Enfermedad , Adulto Joven
2.
Scand J Gastroenterol ; 47(7): 770-7, 2012 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-22519894

RESUMEN

OBJECTIVE: In contrast to coeliac disease (CD), the mechanism behind non-coeliac gluten sensitivity (NCGS) is unclear. The aims of the study were to measure the presence of somatization, personality traits, anxiety, depression, and health-related quality of life in NCGS individuals compared with CD patients and healthy controls, and to compare the response to gluten challenge between NCGS and CD patients. MATERIAL AND METHODS: We examined 22 CD patients and 31 HLA-DQ2+ NCGS patients without CD, all on a gluten-free diet. All but five CD patients were challenged orally for 3 days with gluten; symptom registration was performed during challenge. A comparison group of 40 healthy controls was included. Patients and healthy controls completed questionnaires regarding anxiety, depression, neuroticism and lie, hostility and aggression, alexithymia and health locus of control, physical complaints, and health-related quality of life. RESULTS: The NCGS patients reported more abdominal (p = 0.01) and non-abdominal (p < 0.01) symptoms after gluten challenge than CD patients. There were no significant differences between CD and NCGS patients regarding personality traits, level of somatization, quality of life, anxiety, and depressive symptoms. The somatization level was low in CD and NCGS groups. Symptom increase after gluten challenge was not related to personality in NCGS patients. CONCLUSIONS: NCGS patients did not exhibit a tendency for general somatization. Personality and quality of life did not differ between NCGS and CD patients, and were mostly at the same level as in healthy controls. NCGS patients reported more symptoms than CD patients after gluten challenge.


Asunto(s)
Enfermedad Celíaca/psicología , Glútenes/efectos adversos , Calidad de Vida/psicología , Trastornos Somatomorfos/psicología , Adulto , Análisis de Varianza , Ansiedad/complicaciones , Enfermedad Celíaca/complicaciones , Enfermedad Celíaca/fisiopatología , Distribución de Chi-Cuadrado , Depresión/complicaciones , Diarrea/etiología , Dieta Sin Gluten , Femenino , Glútenes/inmunología , Antígenos HLA-DQ , Humanos , Masculino , Persona de Mediana Edad , Personalidad , Trastornos Somatomorfos/complicaciones , Trastornos Somatomorfos/fisiopatología , Encuestas y Cuestionarios
3.
Am J Gastroenterol ; 106(7): 1318-24, 2011 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-21364548

RESUMEN

OBJECTIVES: Investigation of uncertain celiac disease (CD) in patients already on a gluten-free diet (GFD) is difficult. We evaluated HLA-DQ2-gliadin tetramers for detection of gluten-specific T cells in peripheral blood and histological changes in the duodenum after a short gluten challenge as a diagnostic tool. METHODS: HLA-DQ2+ individuals on a GFD for at least 4 weeks were investigated; 35 with uncertain diagnosis, 13 CD patients, and 2 disease controls. All participants had a challenge with four slices of gluten-containing white bread, daily for 3 days (d1-d3). An esophagogastroduodenoscopy with biopsy sampling was done on d0 and d4. Biopsies were scored according to revised Marsh criteria. Peripheral blood CD4+ T cells were isolated, stained with HLA-DQ2-gliadin peptide tetramers, and analyzed by flow cytometry on d0 and d6. RESULTS: After challenge, a positive tetramer test was seen in 11/13 CD patients. Four of these subjects also showed typical histological changes on challenge. Of the 35 patients with uncertain diagnosis, 3 were diagnosed with CD. Two of these three patients had both positive tetramer staining and histological changes in biopsies after challenge. CONCLUSIONS: Tetramer staining for gluten-specific T cells is a sensitive method in detecting an immune response in CD patients after a short gluten challenge. The prevalence of CD in the group with self-prescribed GFD was about 10%.


Asunto(s)
Linfocitos T CD4-Positivos/inmunología , Enfermedad Celíaca/sangre , Enfermedad Celíaca/diagnóstico , Tracto Gastrointestinal/inmunología , Glútenes/inmunología , Antígenos HLA-DQ/inmunología , Adolescente , Adulto , Anciano , Biopsia , Pan , Linfocitos T CD4-Positivos/metabolismo , Enfermedad Celíaca/inmunología , Enfermedad Celíaca/patología , Técnicas de Diagnóstico del Sistema Digestivo , Endoscopía del Sistema Digestivo , Femenino , Citometría de Flujo , Antígenos HLA-DQ/metabolismo , Humanos , Masculino , Persona de Mediana Edad , Adulto Joven
4.
J Ren Nutr ; 14(2): 101-8, 2004 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-15060875

RESUMEN

OBJECTIVE: To compare dietary intake and health-related quality of life approximately 6 to 10 weeks after renal transplantation in patients living at home and at a patient hotel, and how the patients were following a heart-healthy diet according to the current American Heart Association guidelines. DESIGN: Cross-sectional observational study. SETTING: Outpatient clinic at Rikshospitalet University Hospital, Norway. PATIENTS: Forty renal transplant patients, 20 patients (14 men and 6 women) in both groups. There were 4 diabetic patients in each group. METHODS: Dietary intake was assessed by 4-day dietary records. Health-related quality of life was investigated by the SF-36 questionnaire. The main outcome variables were daily energy intake and intakes of protein, total fat, saturated fat, cholesterol, fiber, and fruit and vegetables. The variables were tested by 2-sample t-tests, and significance was set at.05. RESULTS: There was no statistically significant difference in daily energy intake between the groups (P =.08), but there were significantly higher daily intakes of protein (P =.003), total fat (P =.03), monounsaturated fat (P =.02), cholesterol (P =.04), fiber (P =.02), calcium (P =.03), and fruit and vegetables (P =.03) in the group living at the patient hotel. The mean intake of saturated fat was 14.5% of total energy in the group living at home and 14.6% in the group living at the patient hotel. There were no significant differences in health-related quality of life between the groups. CONCLUSION: The results suggest that there are differences in dietary intake in renal transplant patients living at home compared with those at a patient hotel. It seems that neither of the groups follows current guidelines for reducing the risk of cardiovascular disease.


Asunto(s)
Dieta/normas , Servicios de Alimentación/normas , Vivienda/clasificación , Trasplante de Riñón , Enfermedades Cardiovasculares/prevención & control , Estudios Transversales , Registros de Dieta , Femenino , Humanos , Masculino , Persona de Mediana Edad , Noruega , Calidad de Vida , Encuestas y Cuestionarios
5.
Tidsskr Nor Laegeforen ; 123(22): 3237-40, 2003 Nov 20.
Artículo en Noruego | MEDLINE | ID: mdl-14714019

RESUMEN

Life-long gluten-free diet is the established therapy for coeliac disease and dermatitis herpetiformis. Diet therapy allows the intestinal mucosa to recover, improves nutrient malabsorption, osteoporosis and a weakened general condition. A gluten-free diet is without wheat, rye and barley and related products. Oats tested free of contamination by other cereals has recently been allowed for adult coeliac patients, but concern still remains regarding its general safety. Gluten-free flour mixes contain more starch and less proteins, vitamins, minerals and fibre compared to regular flour. Recently some questions have been raised as to the nutritional quality of the gluten-free diet. Successful therapy with gluten-free diet requires motivation and dietary counselling, including knowledge of the nutritional value of foods, labelling of prepackaged foods and practical training in cooking. The local chapters of the Norwegian Coeliac Society are active partners, as are the clinical nutritionists that work in most major hospitals. The physician making the diagnosis has a duty to see to it that all coeliac patients get adequate dietary counselling and management.


Asunto(s)
Enfermedad Celíaca/dietoterapia , Dermatitis Herpetiforme/dietoterapia , Adulto , Enfermedad Celíaca/complicaciones , Dermatitis Herpetiforme/complicaciones , Servicios Dietéticos , Glútenes/administración & dosificación , Glútenes/efectos adversos , Humanos , Resultado del Tratamiento
6.
Scand J Gastroenterol ; 43(2): 161-5, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18224563

RESUMEN

OBJECTIVE: Coeliac disease is effectively treated with a gluten-free diet devoid of wheat, rye, barley and related cereals. Oats has until recently also been considered harmful but is now allowed in several countries. We have, however, identified three adult coeliac disease patients who developed a flare of active coeliac disease after ingestion of oats, which suggests that oats might not be entirely innocent in coeliac disease. It is known that patients with untreated coeliac disease have elevated IgA antibodies to oat prolamins. The objective of this study was to investigate whether levels of IgA against oats were increased in treated, adult coeliac disease patients. MATERIAL AND METHODS: Serum was collected from 136 adult patients with treated coeliac disease and 139 controls. Eighty-two of the coeliac disease patients had been taking oats as part of their gluten-free diet for 6 months or more. IgA against oats avenin, wheat gliadin and tissue transglutaminase was tested with ELISA. RESULTS: No significant differences were found in IgA against oats in oats-eating and non-oats-eating coeliac disease patients. Both groups had increased levels of IgA against wheat, oats and tissue transglutaminase compared to healthy controls. A significant positive correlation was found between anti-avenin and antigliadin IgA (p<0.0001), and between anti-avenin and anti-tissue transglutaminase IgA (p=0.0012). CONCLUSIONS: Ingestion of oats does not cause increased levels of IgA against oats in adult coeliac disease patients on a gluten-free diet. The findings support the notion that most adult coeliac disease patients can tolerate oats.


Asunto(s)
Avena/inmunología , Enfermedad Celíaca/dietoterapia , Enfermedad Celíaca/inmunología , Inmunoglobulina A/sangre , Proteínas de Plantas/inmunología , Avena/efectos adversos , Ensayo de Inmunoadsorción Enzimática , Femenino , Gliadina/inmunología , Glútenes/administración & dosificación , Humanos , Masculino , Persona de Mediana Edad , Proteínas de Plantas/efectos adversos , Prolaminas , Transglutaminasas/inmunología
7.
Clin Transplant ; 21(2): 246-51, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17425753

RESUMEN

BACKGROUND: Postprandial hyperglycemia (PPHG) frequently occurs among renal transplant recipients (RTR). Reduced early insulin response (EIR) after a meal leads to impaired suppression of endogenous glucose production and subsequently PPHG, which is a risk factor for cardiovascular disease. Nateglinide is a rapid acting insulin secretagogue inducing an EIR after a meal. Our main objective was to investigate the safety and effect of nateglinide treatment on postprandial plasma glucose excursions and insulin secretion in RTR with PPHG. PATIENTS AND METHODS: A total of 14 Caucasian RTR with new-onset diabetes mellitus (NODM; n = 6) or impaired glucose tolerance (IGT; n = 8) were included. The insulin response and glucose excursions were measured for 240 min after a standardized liquid meal at baseline and after two-wk treatment with nateglinide. RESULTS: Treatment with nateglinide was followed by a significant decrease in mean two-h plasma glucose from 10.5 mmol/L (3.1) to 7.6 mmol/L (2.1; p < 0.001) and a decline in total postprandial area under the curve (AUC) of glucose concentration (p < 0.001). Both estimated EIR and the late insulin response increased significantly (p = 0.008 and p = 0.003, respectively). No serious adverse event was observed during the study period. CONCLUSIONS: Treating RTR with nateglinide for two-wk significantly improved PPHG, increased the insulin response following a standardized meal and was well tolerated.


Asunto(s)
Glucemia/efectos de los fármacos , Ciclohexanos/farmacología , Hiperglucemia/prevención & control , Hipoglucemiantes/farmacología , Insulina/metabolismo , Trasplante de Riñón/fisiología , Fenilalanina/análogos & derivados , Periodo Posprandial/efectos de los fármacos , Anciano , Ciclohexanos/administración & dosificación , Ciclohexanos/uso terapéutico , Femenino , Humanos , Hipoglucemiantes/administración & dosificación , Hipoglucemiantes/uso terapéutico , Secreción de Insulina , Masculino , Persona de Mediana Edad , Nateglinida , Fenilalanina/administración & dosificación , Fenilalanina/farmacología , Fenilalanina/uso terapéutico , Periodo Posprandial/fisiología
8.
Clin Gastroenterol Hepatol ; 3(9): 875-85, 2005 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-16234025

RESUMEN

BACKGROUND & AIMS: Patients with celiac disease (CD) who do not improve or exhibit villous atrophy on a gluten-free diet may have type 1 refractory CD (RCD) with a polyclonal mucosal T-cell infiltrate, or type 2 RCD with a monoclonal infiltrate, also termed cryptic T-cell lymphoma. Both conditions are difficult to treat. Here we describe the effects of a nonimmunogenic elemental diet on clinical symptoms and mucosal immunopathology in type 1 RCD. METHODS: Ten CD patients on a strict gluten-free diet were diagnosed with type 1 RCD after extensive clinical evaluation in a tertiary referral hospital. A 4-week amino-acid-based liquid elemental diet regimen was given with no other treatment, except in 1 patient who also received methotrexate. Duodenal biopsy specimens were obtained before and after treatment for histologic assessment, immunophenotyping of intraepithelial lymphocytes, T-cell receptor clonality, mucosal interleukin (IL)-15 expression, flow-cytometric analysis of interferon (IFN)-gamma-secreting T cells, and whole biopsy specimen IFN-gamma messenger RNA determination. RESULTS: Nine patients completed the treatment; however, 1 patient did not tolerate the diet. Histologic improvement and reduced epithelial IL-15 were seen in 8 patients, whereas IFN-gamma-secreting mucosal T cells and IFN-gamma messenger RNA levels decreased in 4 and 7 patients, respectively. Clinical improvement was noted in 6 patients, with 1 patient showing normalization of hypoalbuminemia. Three patients could discontinue their total parenteral nutrition. CONCLUSIONS: Persistent mucosal IFN-gamma and IL-15 production often occurs in type 1 RCD despite conventional treatment. Elemental diet is a therapeutic option that can provide long-term immunopathologic and clinical improvement of this difficult condition.


Asunto(s)
Enfermedad Celíaca/dietoterapia , Enfermedad Celíaca/patología , Alimentos Formulados , Inmunofenotipificación , Mucosa Intestinal/inmunología , Mucosa Intestinal/patología , Adulto , Anciano , Biopsia , Índice de Masa Corporal , Complejo CD3/metabolismo , Linfocitos T CD8-positivos/metabolismo , Enfermedad Celíaca/inmunología , Enfermedad Celíaca/metabolismo , Dieta con Restricción de Proteínas , Duodeno/inmunología , Duodeno/patología , Femenino , Citometría de Flujo , Humanos , Inmunohistoquímica , Interferón gamma/metabolismo , Interleucina-15/metabolismo , Mucosa Intestinal/metabolismo , Masculino , Persona de Mediana Edad , Noruega , ARN Mensajero/metabolismo , Receptores de Antígenos de Linfocitos T/metabolismo , Linfocitos T/metabolismo , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA